Showing 4 of 24 recruiting trials for “primary-mediastinal-large-b-cell-lymphoma”
R-CDOP Regimen in the Treatment of Newly Diagnosed Non-Hodgkin's Lymphoma With High Tumor Burden
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
👨⚕️ Mats Jerkeman, Department of Oncology, Skåne University Hospital📍 69 sites📅 Started Aug 2020View details ↗
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →